Lyell Immunopharma (LYEL) Treasury Shares (2020 - 2026)

Lyell Immunopharma's Treasury Shares history runs 7 years deep, the most recent figure standing at $531542.0 for Q1 2026.

• In Q1 2026, Treasury Shares fell 80.34% year-over-year to $531542.0; the TTM figure through Mar 2026 stood at $531542.0 (down 80.34% YoY), while the FY2025 annual figure was $306415.0, up 8.97% from the prior year.
• Treasury Shares came in at $531542.0 for Q1 2026 at Lyell Immunopharma, up from $306415.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $5.2 million in Q2 2024 to a low of $84047.0 in Q3 2025.
• A 5-year average of $1.8 million and a median of $1.6 million in 2022 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares soared 180.72% in 2023 and tumbled 98.1% in 2025, its largest moves.
• Lyell Immunopharma's Treasury Shares stood at $872077.0 in 2022, then surged by 137.69% to $2.1 million in 2023, then plunged by 86.43% to $281190.0 in 2024, then grew by 8.97% to $306415.0 in 2025, then surged by 73.47% to $531542.0 in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $531542.0, $306415.0, and $84047.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison